Diploma (LON:DPLM) PT Raised to GBX 3,800 at Berenberg Bank

Diploma (LON:DPLM) had its price objective upped by Berenberg Bank from GBX 3,500 ($43.79) to GBX 3,800 ($47.54) in a report published on Monday, Digital Look reports. They currently have a buy rating on the stock.

Separately, Shore Capital reaffirmed a buy rating on shares of Diploma in a research note on Monday. One analyst has rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of Hold and a consensus price target of GBX 3,028.57 ($37.89).

Diploma Trading Down 0.5 %

Shares of DPLM traded down GBX 16 ($0.20) on Monday, reaching GBX 3,342 ($41.81). 111,299 shares of the company’s stock were exchanged, compared to its average volume of 257,755. The company has a current ratio of 1.87, a quick ratio of 0.80 and a debt-to-equity ratio of 33.34. The stock has a market capitalization of £4.48 billion, a P/E ratio of 3,559.57, a price-to-earnings-growth ratio of 2.82 and a beta of 0.68. The business has a 50 day moving average price of GBX 2,967.34 and a two-hundred day moving average price of GBX 3,025.20. Diploma has a 12 month low of GBX 2,524.50 ($31.58) and a 12 month high of GBX 3,400 ($42.54).

Diploma Increases Dividend

The business also recently disclosed a dividend, which will be paid on Friday, February 2nd. Stockholders of record on Thursday, January 18th will be given a dividend of GBX 40 ($0.50) per share. This is an increase from Diploma’s previous dividend of $16.50. The ex-dividend date of this dividend is Thursday, January 18th. This represents a dividend yield of 1.32%. Diploma’s dividend payout ratio is currently 5,851.06%.

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, rest of Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies clinical diagnostics instrumentation and products, instrumentation and consumables, specialty surgical devices, and related consumables and services to public hospitals, private clinics, pathology laboratories, scientific research, and medical segments; surgical equipment for hospital operating rooms; and distributes laboratory diagnostics, specialty medical devices, devices, equipment, and patient monitoring technologies used in operating theatres, as well as medically supervised nutrition.